Craneware PLC
LSE:CRW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Craneware PLC
LSE:CRW
|
UK |
|
W
|
Wasu Media Holding Co Ltd
SZSE:000156
|
CN |
Craneware PLC
Craneware PLC, a prominent player in the healthcare software industry, crafts its narrative in the pursuit of financial optimization for hospitals across the United States. Established in 1999, Craneware recognized that hospitals were grappling with intricate billing processes and revenue cycle inefficiencies. By focusing on developing comprehensive software solutions, Craneware has strategically positioned itself to help these institutions navigate the labyrinth of medical billing and coding. With its suite of services, including charge capture, pricing analytics, and cost management, Craneware aids hospitals in maximizing their revenue and ensuring compliance. This focus allows healthcare providers to transform data into actionable insights, which not only streamlines operations but also enhances fiscal performance.
Revenue generation for Craneware comes primarily from its software sales and accompanying support services. The company employs a Software as a Service (SaaS) model, wherein clients subscribe to its offerings on a recurring basis, ensuring a steady inflow of income while fostering long-term business relationships. This model capitalizes on the growing demand for cloud-based solutions, providing clients with the flexibility and scalability required in a constantly evolving healthcare landscape. Craneware’s unique positioning at the intersection of healthcare and financial management means its growth is not just dependent on acquiring new clients, but also on deepening engagements with existing ones, providing upgrades and enhancements that serve the ever-changing needs of the healthcare industry.
Craneware PLC, a prominent player in the healthcare software industry, crafts its narrative in the pursuit of financial optimization for hospitals across the United States. Established in 1999, Craneware recognized that hospitals were grappling with intricate billing processes and revenue cycle inefficiencies. By focusing on developing comprehensive software solutions, Craneware has strategically positioned itself to help these institutions navigate the labyrinth of medical billing and coding. With its suite of services, including charge capture, pricing analytics, and cost management, Craneware aids hospitals in maximizing their revenue and ensuring compliance. This focus allows healthcare providers to transform data into actionable insights, which not only streamlines operations but also enhances fiscal performance.
Revenue generation for Craneware comes primarily from its software sales and accompanying support services. The company employs a Software as a Service (SaaS) model, wherein clients subscribe to its offerings on a recurring basis, ensuring a steady inflow of income while fostering long-term business relationships. This model capitalizes on the growing demand for cloud-based solutions, providing clients with the flexibility and scalability required in a constantly evolving healthcare landscape. Craneware’s unique positioning at the intersection of healthcare and financial management means its growth is not just dependent on acquiring new clients, but also on deepening engagements with existing ones, providing upgrades and enhancements that serve the ever-changing needs of the healthcare industry.
Revenue & Profit: Revenue grew 6% to $105.7 million and adjusted EBITDA rose 10% to $33.4 million (32% margin), with adjusted basic EPS up 16% to $0.587.
Recurring strength: ARR increased to $184.2 million (from $177.3m), with net revenue retention of 103% and customer retention above 90%.
340B disruption: HRSA's rebate pilot and its subsequent pause materially affected the timing and classification of revenue (shelter and rebate licenses), softening ARR recognition this half.
AI as enabler: Management views AI as a productivity accelerator for their SaaS, leveraging scale, clinical data and developer use of tools like GitHub Copilot to speed product delivery and QA.
Product & go-to-market: New product launches (Trisus Labor & Productivity and Reimbursement Intelligence) will be presented at HIMSS, expanding TAM and in-market expansion opportunities.
Balance sheet & returns: Operating cash conversion was 85%; bank debt reduced to $23.4 million; interim dividend raised to 15p and a $25 million share buyback was announced.
Operational wins: New hospital wins improved (new hospital wins represented 12% of new sales vs ~2% prior year) and platform (nonrecurring) revenue doubled to $14.6 million.
